Global Erythropoietin Market Forecast 2017-2027

LONDON, June 1, 2017 /PRNewswire/ -- Report Details
The global erythropoietin market is expected to grow at a CAGR of 7.8% in the first half of the forecast period and CAGR of 4.8% in the second half of the forecast period. The market is estimated at $7.9bn in 2016 and $16.5bn in 2027.


Download the full report: https://www.reportbuyer.com/product/4930030/



How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 84 tables and 93 figures – all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global erythropoietin market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Erythropoietin Market forecasts from 2017-2027

• Revenue forecasts of global erythropoietin market, segmented by product type:
- Epoetin Alfa
- Epoetin Beta
- Darbepoetin Alfa
- Biosimilars
- Others

This section also discusses the leading drugs as well as SWOT analysis of each submarket.

• Revenue forecasts of global erythropoietin market, segmented by application:
- Anemia (Cancer and HIV Treatment)
- Kidney Disorders (ESRD and Dialysis)
- Others

• Revenue forecasts of global erythropoietin API manufacturing market, segmented by contract manufacturing and in-house manufacturing

• Erythropoietin Leading Regional Market forecasts from 2017-2027 covering North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.



Forecast for each regional market is further segmented by product type, application and country:
- US
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- Japan
- India
- Rest of Asia-Pacific
- Brazil
- Mexico
- Rest of Latin America
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa

• Assessment of selected leading companies that hold major market shares in the erythropoietin market:
- Amgen
- Johnson & Johnson
- Roche
- Biocon
- 3SBio
- Pfizer
- Kyowa Hakko Kirin Co Ltd
- LG Life Sciences Limited
- Intas Pharmaceuticals Ltd
Download the full report: https://www.reportbuyer.com/product/4930030/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-erythropoietin-market-forecast-2017-2027-300467509.html

SOURCE ReportBuyer